Background— Anderson-Fabry disease (AFD) is a rare but underdiagnosed intracellular
lipid disorder that can cause left ventricular hypertrophy (LVH). Lipid is known to shorten the …

Objectives : The aims of the study were to explore the ability of native myocardial T1
mapping by cardiac magnetic resonance to: 1) detect cardiac involvement in patients with …

Aims To assess the prognostic value of myocardial pre-contrast T1 and extracellular volume
(ECV) in systemic amyloid light-chain (AL) amyloidosis using cardiovascular magnetic …

Objective To measure and assess the significance of myocardial extracellular volume (ECV),
determined non-invasively by equilibrium contrast cardiovascular magnetic resonance, as …

Objectives : The aim of this study was to determine the accuracy of the contrast “bolus only”
T1 mapping cardiac magnetic resonance (CMR) technique for measuring myocardial …

Background— Cardiac involvement predicts outcome in systemic AL amyloidosis and influences
therapeutic options. Current methods of cardiac assessment do not quantify myocardial …

Background Quantitative T1-mapping is rapidly becoming a clinical tool in cardiovascular
magnetic resonance (CMR) to objectively distinguish normal from diseased myocardium. The …

Objectives : This study aimed to determine whether remote ischemic conditioning (RIC)
initiated prior to primary percutaneous coronary intervention (PPCI) could reduce myocardial …

Background Myocardial extracellular volume (ECV) is elevated in fibrosis or infiltration and
can be quantified by measuring the haematocrit with pre and post contrast T1 at sufficient …

Background Cardiovascular magnetic resonance (CMR) derived native myocardial T1 is
decreased in patients with Fabry disease even before left ventricular hypertrophy (LVH) occurs …